Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Cellular Biochemistry|March 19, 2008
CBF/NF-Y controls endoplasmic reticulum stress induced transcription through recruitment of both ATF6(N) and TBPRong Luo, Jing-Fang Lu, Qianghua Hu, et al.
Nucleic Acids Research|November 14, 2006
Inhibition of CBF/NF-Y mediated transcription activation arrests cells at G2/M phase and suppresses expression of genes activated at G2/M phase of the cell cycleQianghua Hu, Jing-Fang Lu, Rong Luo, et al.
Plos One|April 21, 2010
Identification of SOX9 interaction sites in the genome of chondrocytesChun-do Oh, Sankar N Maity, Jing-Fang Lu, et al.
The Prostate|March 30, 2012
Hedgehog signaling inhibition by the small molecule smoothened inhibitor GDC-0449 in the bone forming prostate cancer xenograft MDA PCa 118bMaria Karlou, Jing-Fang Lu, Guanglin Wu, et al.
Plos One|December 24, 2011
Androgen regulation of 5α-reductase isoenzymes in prostate cancer: implications for prostate cancer preventionJin Li, Zhiyong Ding, Zhengxin Wang, et al.
Scientific Reports|October 18, 2016
Targeting of CYP17A1 Lyase by VT-464 Inhibits Adrenal and Intratumoral Androgen Biosynthesis and Tumor Growth of Castration Resistant Prostate CancerSankar N Maity, Mark A Titus, Revekka Gyftaki, et al.
Cancer Research|June 15, 2011
BMP4 promotes prostate tumor growth in bone through osteogenesisYu-Chen Lee, Chien-Jui Cheng, Mehmet A Bilen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2012
Activation of β-catenin signaling in androgen receptor-negative prostate cancer cellsXinhai Wan, Jie Liu, Jing-Fang Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2011
Modeling a lethal prostate cancer variant with small-cell carcinoma featuresVassiliki Tzelepi, Jiexin Zhang, Jing-Fang Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2015
Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate CancersAna M Aparicio, Li Shen, Elsa Li Ning Tapia, et al.
Pageof 1